Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

11.8%

2 terminated out of 17 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

35%

6 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results80% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (6)
P 1 (2)
P 3 (4)
P 4 (2)

Trial Status

Completed8
Unknown3
Withdrawn3
Terminated2
Enrolling By Invitation1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06965842Not ApplicableEnrolling By Invitation

The Video System to Provide a Developmental Training Guide for Preterm Infants

NCT03858816Not ApplicableWithdrawnPrimary

Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants

NCT02415530Not ApplicableCompletedPrimary

Early Family Based Intervention in Preterm Infants

NCT03876704Phase 3Unknown

Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants

NCT02741934CompletedPrimary

Cognitive and Behavioral Outcomes of School-aged Children Who Were Born Preterm

NCT02337088Not ApplicableTerminatedPrimary

Delayed Cord Clamping in Very Low Birth Weight Infants

NCT01443091Not ApplicableCompletedPrimary

Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants

NCT02383264Completed

Splanchnic Oxygenation After the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance.

NCT01434849Phase 1Terminated

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

NCT02731092Phase 1UnknownPrimary

Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants

NCT00470743Phase 4Withdrawn

Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies

NCT01287507Not ApplicableCompleted

Lactoferrin Prophylaxis in VLBW and Regulator T-cells

NCT01531192Phase 4CompletedPrimary

Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

NCT01531179Phase 3Completed

Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants

NCT00033917Phase 3Completed

Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

NCT01315821Phase 3Unknown

Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants

NCT00425581Withdrawn

N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life

Showing all 17 trials

Research Network

Activity Timeline